Minimally invasive surgery (MIS) for liver and pancreas resections is associated with significantly lower hospital charges compared to traditional open surgery.
Robotic surgery adoption in hepatopancreatic procedures increased from 1.7% to 4.2% between 2016 and 2020, yet open surgery remains the dominant modality (87.7%).
Laparoscopic pancreatic resections yield the highest cost savings, with a reduction in adjusted charges of approximately $52,120 relative to open approaches.
The presence of postoperative complications and late discharge timing are the most potent predictors of increased hospital charges, adding over $80,000 to the median cost.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.